Cargando…

The Pharmacology, Efficacy, and Safety of Rivaroxaban in Obese Patient Populations

Cardiovascular disease (CVD) remains the leading cause of death in the USA. Several risk factors have been identified, and obesity has become one of prominent concern. Excessive weight is considered a risk factor for CVD based on evidence linking it to a hypercoagulable state. Considering the preval...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashton, Veronica, Mudarris, Lana, Moore, Kenneth T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089078/
https://www.ncbi.nlm.nih.gov/pubmed/32803514
http://dx.doi.org/10.1007/s40256-020-00434-w